All News
PIANO Study - Safety of Biologics in Pregnancy
The results of the long awaited PIANO study have been reported in the journal Gastroenterology, showing that pregnant women with IBD may safely receive biologic or thiopurine therapy throughout the pregnancy without substantial added risk to the unborn or mother.
Read Article
Colchicine Approval Took a Huge Toll on CMS
d
Colchicine, the old gout drug often cited as a cheap anti-inflammatory, hasn't been such a good deal since FDA approval, a study in JAMA Internal Medicine showed.
Read Article
Is COVID19 infection bad for rheumatic disease patients? Dr. Jeff Curtis ( @RADoctor) reviews abstract L01 presented at #ACR20.
https://t.co/hm7geJKzNt https://t.co/gAY6k7ywLw
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @ejdein1 : Draft #ACR20 Rx Recommendations for RA: MTX monotherapy conditionally rec over csDMARD dual or triple Rx, MTX+TNFi @RheumNow https://t.co/HUucJOgQgN https://t.co/xJB2zU1y2U
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Jack Cush interviews Dr. Petri about the comparative value of lupus anticoagulant vs. other antiphospholipid antibody tests and their role in CVA or MI. #ACR20
https://t.co/IyeRDzw4BC https://t.co/k5LpJ8kkaz
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @RHEUMarampa : Novel predictors of early mortality in a cohort of GCA pts from Portugal:
🚩Older age at dx
🚩Tongue claudication
🚩Prior tx w/ anticoag
BP treatment at dx - predictor of early survival. @RheumNow #ACR20 abs1935 https://t.co/vCi2gMCmKE https://t.co/HuTv1p8Yua
Links:
Dr. John Cush RheumNow ( View Tweet)
The Lungs: The Alpha and Omega of RA with Dr. Jonathan Kay #ACR20
https://t.co/zhCRaeKOfu https://t.co/zVwgzu9ULs
Links:
Dr. John Cush RheumNow ( View Tweet)
Blood Brain Barrier Leakage in SLE: Dr. Janet Pope ( @Janetbirdope) reviews abstract #1508 from #ACR20 meeting.
https://t.co/JSHyuGtv3O https://t.co/pGaskVnCfi
Links:
Dr. John Cush RheumNow ( View Tweet)
Revisit Day 1 of #ACR20 through the RheumNow podcast. Follow the link below or find us on Apple/Android podcasts.
https://t.co/Hj4uIYzFuL https://t.co/WXecOcVDQR
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @ejdein1 : Draft #ACR20 Rx Recs for RA: Use MTX, starting oral but remember MTX tricks to maximize success. Folic acid, split dosing, SubQ all keys per Dr. O'Dell to maximize @RheumNow. https://t.co/OEAGi0bSZH https://t.co/aHsHF1Vm4l
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @ejdein1 : Draft #ACR20 Rx Recs for RA: on max tolerated MTX - add bio or tsDMARD conditional recommendation over triple therapy (MTX, HCQ, SSZ). @RheumNow. https://t.co/uff7Vj0iKA https://t.co/Tquq7FN86y
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @ejdein1 : Draft #ACR20 Rx Recs for RA: discontinue MTX over biologic or tsDMARD in "patients that strongly want to discontinue", conditional recommendation supported by SEAM-RA Abst#939 @RheumNow https://t.co/2Ozvkq4Rjo https://t.co/xlbKAItFzN
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out our latest article from Dr. Janet Pope ( @Janetbirdope)
How are RA patients doing using telemedicine/virtual care?
https://t.co/YffT28OwgY https://t.co/xnAe3lKL8W
Links:
Dr. John Cush RheumNow ( View Tweet)
(if this is true) Shame on @expressScripts and forcing money driven biologic changes (from secukinumab to ixekizumab) upon patients and doctors. This is soooo wrong! https://t.co/DYKSItCbYL
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @DrMiniDey : Study on #telehealth in #rheumatology patients in the US finds those with #comorbidities and high disease activity are most likely to take up remote consults.
Abs#1962 #ACR20 @RheumNow
https://t.co/8USU39mTPk https://t.co/ioT1b1x4IO
Links:
Dr. John Cush RheumNow ( View Tweet)
Pipeline Therapies for Urate Lowering: Dr. Michael Pillinger
#ACR20
https://t.co/M3ahjjZWK8 https://t.co/Ipc0nowK2t
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out Dr. Kathyrn Dao's blog experience. A rheumatology researcher signs up for the COVID-19 vaccine! https://t.co/B9Wsvo7DJH
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @MeralElRamahiMD :Conditional recommendation to add bDMARD or tsDMARD in RA pts on maximally tolerated dose of MTX over adding HCQ+SSZ (triple therapy) per draft recommendation of new ACR RA treatment guidelines. #ACR20 @ElaineHusniMD https://t.co/tCAbgYi3h0 https://t.co/AoEOJd3pQh
Links:
Dr. John Cush RheumNow ( View Tweet)
How COVID Changed Work: Drs. Rachel Tate, Cassie Calabrese and Mary Hinojos Mamut #ACR20
https://t.co/jyM8NPicZF https://t.co/6zA7Kmgzwi
Links:
Dr. John Cush RheumNow ( View Tweet)
Measuring Disease Activity in Psoriatic Arthritis: Dr. Eric Ruderman ( @JointMD) looks at several abstracts that focus on disease activity measurement in psoriatic arthritis presented at the #ACR20 meeting.
https://t.co/Tu58NDbc51 https://t.co/RGwON4gu7w
Links:
Dr. John Cush RheumNow ( View Tweet)